Mass screening in low-income populations: the challenges of securing diagnostic and treatment services in a national cancer screening program
- PMID: 10946385
- DOI: 10.1215/03616878-25-3-451
Mass screening in low-income populations: the challenges of securing diagnostic and treatment services in a national cancer screening program
Abstract
Funding for many mass screening programs for low-income and uninsured populations provides resources for screening tests, yet only rarely does it provide coverage for necessary follow-up diagnostic and treatment services. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a federally funded initiative that provides cancer screening to low-income uninsured and underinsured women, covers some diagnostic follow-up tests and no treatment services. We conducted in-depth case studies of seven state programs participating in the NBCCEDP to investigate the strategies and approaches being used to secure diagnostic and treatment services. The results suggest that the program relies on a patchwork of resources--at state and local levels--to provide diagnostic and treatment services. This includes a number of components of local safety nets, all of which are unstable and have uncertain futures. Public health disease-screening initiatives need to reconsider the feasibility of continued reliance on case-by-case appeals to the local safety net for diagnostic follow-up and treatment services.
Similar articles
-
Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.Cancer Causes Control. 2010 Jul;21(7):1081-90. doi: 10.1007/s10552-010-9536-3. Epub 2010 Apr 2. Cancer Causes Control. 2010. PMID: 20361353
-
Implementing recommendations for the early detection of breast and cervical cancer among low-income women.MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55. MMWR Recomm Rep. 2000. PMID: 15580731
-
Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.Cancer Causes Control. 2015 May;26(5):671-86. doi: 10.1007/s10552-015-0524-5. Epub 2015 Mar 18. Cancer Causes Control. 2015. PMID: 25783455 Free PMC article.
-
See, Test & Treat: A 5-Year Experience of Pathologists Driving Cervical and Breast Cancer Screening to Underserved and Underinsured Populations.Arch Pathol Lab Med. 2016 Dec;140(12):1411-1422. doi: 10.5858/arpa.2016-0094-SA. Arch Pathol Lab Med. 2016. PMID: 27922769 Review.
-
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.Cancer. 2008 Nov 15;113(10 Suppl):3004-12. doi: 10.1002/cncr.23765. Cancer. 2008. PMID: 18980296 Review.
Cited by
-
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.Curr Oncol. 2016 Jun;23(3):e179-87. doi: 10.3747/co.23.2988. Epub 2016 Jun 9. Curr Oncol. 2016. PMID: 27330355 Free PMC article.
-
Assessing the implementation of a patient navigation intervention for colonoscopy screening.BMC Health Serv Res. 2019 Nov 6;19(1):803. doi: 10.1186/s12913-019-4601-4. BMC Health Serv Res. 2019. PMID: 31694642 Free PMC article.
-
Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005.Am J Public Health. 2010 Sep;100(9):1769-76. doi: 10.2105/AJPH.2009.160184. Epub 2009 Dec 17. Am J Public Health. 2010. PMID: 20019308 Free PMC article.
-
Assessing local capacity to expand rural breast cancer screening and patient navigation: An iterative mixed-method tool.Eval Program Plann. 2017 Apr;61:113-124. doi: 10.1016/j.evalprogplan.2016.11.006. Epub 2016 Nov 23. Eval Program Plann. 2017. PMID: 28011433 Free PMC article.
-
Stakeholders' perceptions and experiences of factors influencing the commissioning, delivery, and uptake of general health checks: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD014796. doi: 10.1002/14651858.CD014796.pub2. Cochrane Database Syst Rev. 2025. PMID: 40110911